New resource for RFS Section members—Renal Cell Carcinoma (RCC): Local Therapies

The Resident, Fellow and Student (RFS) Interventional Oncology Service Line’s latest educational resource focuses on the most widely adopted locoregional therapies for renal cell carcinoma (RCC) and serves as a companion to their December post on RCC disease overview and systemic therapies.

This resource, which is exclusive to medical students and residents, can be accessed within their SIR Connect community.